tirzepatide backorder Update: On December 19th the FDA ruled the tirzepatide shortage was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On FDA sets tirzepatide compounding deadlines

Traditionally medicine has considered a drug as working by blocking a receptor or decreasing/increasing the production of an important compound

Excess reconstitution volume does not dilute the peptide or reduce total dose count it only increases the injection volume per dose

Research shows that appetite-regulating hormones are tied to your body's internal clock

FDA GLP-1 approval to reduce cardiovascular risk in obesity World Health Organization 2025 guideline on GLP-1 medicines for obesity NIH / PubMed cardiovascular and kidney outcomes of GLP-1 in older adults The Lancet eClinicalMedicine GLP-1 use and lower dementia risk in older adults The BMJ gastrointestinal side effects of GLP-1 medications The Lancet Healthy Longevity GLP-1 and sarcopenia risk in frail older adults NIH / PubMed dehydration and GLP-1 therapy ScienceDirect long-term safety considerations for GLP-1 use ScienceDirect monitoring guidance for GLP-1 medications MDWatch Weight-Loss Program See if a GLP-1 is right for you Get a personalized plan from board-certified medical providers who treat seniors every day